Acquisition of Emerald Health Therapeutics, Inc. - Estimated Cost Incurred For Wind-down Of Operation (Details) - Emerald Health Therapeutics, Inc. |
Sep. 30, 2022
USD ($)
|
|---|---|
| Asset Acquisition [Line Items] | |
| Business exit costs, quarter one | $ 970,000 |
| Business exit costs, quarter two | 140,000 |
| Thereafter | 40,000 |
| Total future estimated costs: | $ 1,150,000 |
| X | ||||||||||
- Definition Asset Acquisition, Wind-Down Costs To Be Paid No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Wind-Down Costs To Be Paid, Quarter One No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Wind-Down Costs To Be Paid, Quarter Two No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Wind-Down Costs To Be Paid, Thereafter No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|